This bidirectional regulatory strategy echoes its antiferroptotic effects via the SIRT6/p-NRF2/GPX4 pathway in cataract models.18, 47 GPX4, a key ferroptosis inhibitor, specifically reduces phospholipid hydroperoxides to preserve membrane integrity.49 Here, GPX4 is linked to cataract.